Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
She was the supermodel dubbed 'The Face' in the '80s. Joining OnlyFans in her 60s taught her a lot. - 2Tatiana Schlossberg, JFK's granddaughter, dies at 35 after terminal cancer diagnosis
- 3The most effective method to Redesign the Sound Framework in Your Smash 1500.
- 4German diesel hits new records over Easter weekend
- 5WHO suspends medical evacuations from Gaza following death of contractor in 'security incident'
- China bans storing cremated remains in empty 'bone ash apartments'
- Instructions to Redo Your Kona SUV for Improved Tasteful Allure and Usefulness
- Israel strikes Beirut amid rocket fire from Hezbollah and Iran
- The Significance of Prenuptial Arrangements in Separation Procedures
- 6 Useful Home Espresso Machines
- The Meaning of Breaking the Pen's Nib in Death penalties
- Which European countries have mandatory or voluntary military service
- UN torture cm'tee report flags Israel for allegedly mistreating journalists, detainees, ex-MAG
- Supreme Court case about ‘crisis pregnancy centers’ highlights debate over truthful advertising standards
